Article
09 Jan 2026
The European Parliament And Council Reach Provisional Agreement On The EU "Pharma Package"
AUTHORS CONTENT
Article
03 Dec 2025
SPC Waiver: No MA? UK Says Ok
Article
29 Jul 2025
Proposed Reforms To Regulatory Exclusivities From The European Parliament And Council
Article
08 Jul 2025
G 1/23: Enlarged Board Of Appeal Redefines Prior Art In Europe
Article
07 Jul 2025
G 1/24: EPO's Decision On Claim Interpretation
Article
24 Jun 2025
The EPO's Enlarged Board Of Appeal Has Changed The Interpretation Of Claims When Assessing Patentability
Article
28 Aug 2024
Does A Commercially Available Product Make Your Invention Unpatentable?
Article
04 Jul 2024
G1/24 - Referral To EPO's Enlarged Board Of Appeal On Claim Interpretation
Article
30 Nov 2023
EPO Board Of Appeal Gives Clarity On Interpreting G2/21 When Considering Post-filed Data For Inventive Step (T0116/18)
Article
13 Nov 2023
Description Amendments: Referral To EPO's Enlarged Board Of Appeal Now Imminent
Article
11 Oct 2023
Relief For US Applicants - EPO Takes A Pragmatic Decision On Priority
Article
04 Sep 2023
Proposed Changes To Pharmaceutical Regulatory Exclusivities In Europe
Article
31 Jul 2023
Frequently Asked Questions About The End Of The Ten-Day Rule
Article
11 Apr 2023
EPO Hints At Accepting The ‘PCT Joint Applicants' Approach For Priority
Article
04 Apr 2023
Plausible Or Not? EPO's Enlarged Board Of Appeal Leaves Us In The Dark On Post-filed Data And Inventive Step
Article
31 Oct 2022
Not Implausible? EPO's Enlarged Board Hints At A New Bar For Post-Filed Data